Proteome Remodelling

Proteome Remodelling and Dynamics in Human Skeletal Muscle: Effect of Training

NCT04136457•Morten Hostrup, PhD

Summary

The purpose of the project is to investigate the proteome signature dynamics and remodelling in human skeletal muscle induced by exercise training

Eligibility

Age

18 - 45 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Healthy men and women
•VO2max \> 55 mL/min/kgLM for men and \> 50 for women (only applicable for endurance and sprint training interventions)
•BMI \< 26

Exclusion Criteria

•Chronic disease deemed by the medical doctor to pose a risk or to affect study outcomes
•smoking
•Use of prescription medicine deemed by the medical to affect study outcomes
•Pregnancy

Locations (1)

August Krogh Building

Copenhagen, Denmark

Key Dates

Start Date

October 30, 2019

Primary Completion Date

November 28, 2023

Completion Date

November 28, 2023

Last Updated

December 27, 2023

Enrollment

ACTUAL participants

Conditions

Skeletal Muscle Physiology

Interventions

Endurance training

OTHER

Resistance training

OTHER

Sprint training

OTHER

Testosterone-induced Muscle Memory and Underlying Mechanisms

NCT06188767

Skeletal Muscle Physiology

View study

UNKNOWNNA

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

NCT05692856

Skeletal Muscle Physiology

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 27, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions